Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
Singapore · Delayed Price · Currency is SGD · Price in USD 3.380
+0.010 (0.30%)
Feb 9, 2026, 5:09 PM SGT
62.50% (1Y)
| Market Cap | 5.76B +56.5% |
| Revenue (ttm) | 972.89M -33.3% |
| Net Income | 648.69M +283.7% |
| EPS | 0.84 +285.0% |
| Shares Out | n/a |
| PE Ratio | 8.88 |
| Forward PE | n/a |
| Dividend | 0.67 (22.94%) |
| Ex-Dividend Date | Jan 30, 2026 |
| Volume | 202,800 |
| Average Volume | 244,995 |
| Open | 3.380 |
| Previous Close | 3.370 |
| Day's Range | 3.360 - 3.460 |
| 52-Week Range | 1.990 - 3.500 |
| Beta | n/a |
| RSI | 59.39 |
| Earnings Date | Mar 31, 2026 |